Section a2: patient date of birth was inadvertently added in initial report and should have been removed due to patient privacy laws.Manufacturer's investigation conclusion: a direct correlation between heartmate (hm) 3 left ventricular assist system (lvas), serial number (b)(6), and the reported event could not be conclusively determined through this evaluation.Additionally, a specific cause for the patient's infection could not be conclusively determined.The patient remains ongoing on hm3 lvas, serial number (b)(6), and no further events have been reported at this time.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped on (b)(6) 2020.Review of the sterilization and packaging documentation in the device history records found no deviations from manufacturing specifications.The heartmate 3 lvas ifu, rev.C, and the heartmate 3 patient handbook, rev.D, are currently available.Section 1 of the ifu, ¿introduction¿, lists potential adverse events including infection (local, driveline, and pump pocket), that may be associated with the use of heartmate 3 left ventricular assist system.Section 6 of the ifu, ¿patient care and management¿, lists infection as a potential late postimplant complication.Several sections of the ifu and patient handbook provide care instructions regarding how to prevent infection as well as suggested responses in the event of infection.No further information was provided.The manufacturer is closing the file on this event.
|